CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $105.05 ($10,505,474)
- 4 Open-market sale Chief Information Officer sold 2,000 shares at $104.60 ($209,204)
- 4 Open-market sale Director sold 1,250 shares at $105.00 ($131,250)
- 4 Open-market sale Chief Technology Officer sold 22,935 shares at an average $105.43 ($2,417,980)
- 4 Open-market sale Chief Commercial Officer sold 31,452 shares at an average $103.07 ($3,241,621)
- 4 Open-market sale Chief Financial Officer sold 80,362 shares at an average $103.14 ($8,288,742)
- 4 Open-market sale Director sold 28,611 shares at an average $107.19 ($3,066,817)
- 4 Planned sale Chief People Officer sold 55,167 shares at an average $105.97 ($5,846,163)
- 4 Option exercise Director acquired 155 shares (option exercise)
- 4 Option exercise Director acquired 264 shares (option exercise)
- 4 Planned sale Director sold 116 shares at $96.25 ($11,165)
- 4 Option exercise Director acquired 232 shares (option exercise)
- 4 Option exercise Director acquired 250 shares (option exercise)
- 4 Open-market sale Director sold 1,500 shares at an average $95.19 ($142,780)
- 4 Open-market sale Chief Legal Officer sold 8,996 shares at $96.25 ($865,865)
- 4 Option exercise Director acquired 154 shares (option exercise)
- 4 Option exercise Director acquired 3,167 shares (option exercise)
- 4 Option exercise Director acquired 232 shares (option exercise)
- 4 Planned sale Director sold 116 shares at $66.95 ($7,766)
- 4 Planned sale Director sold 26 shares at $66.95 ($1,741)
Page 9 of 44 · 878 filings